LONG TERM EFFECT AND TOLERANCE OF ULIPRISTAL ACETATE IN Charcot-Marie-TOOTH DISEASE TYPE 1A (UPACOMT)

Registry ID
EUCTR2015-001716-36
Source registry
EUCTR
Status
Completed
Phase
PHASE2
Sponsor
HÔPITAUX UNIVERSITAIRES DE STRASBOURG
Start date
2015-08-03
Completion date
2018-02-26
Last update
2026-08-16

Conditions

Summary

To evaluate the biological effect of ulipristal acetate, a selective modulator of the progesterone receptor in CMT1A in humans, on the mRNA expression of the PMP22 in a skin biopsy.

Locations

View on source registry